Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Seda Tolu"'
Autor:
Kai Wang, Anthony K. Guzman, Zi Yan, Shouping Zhang, Michael Y. Hu, Mehdi B. Hamaneh, Yi-Kuo Yu, Seda Tolu, Jinghang Zhang, Holly E. Kanavy, Kenny Ye, Boris Bartholdy, Eric E. Bouhassira
Publikováno v:
Cell Reports, Vol 26, Iss 10, Pp 2580-2592.e7 (2019)
Summary: Efficiency of reprogramming of human cells into induced pluripotent stem cells (iPSCs) has remained low. We report that individual adult human CD49f+ long-term hematopoietic stem cells (LT-HSCs) can be reprogrammed into iPSCs at close to 50%
Externí odkaz:
https://doaj.org/article/aed2c90697724a36a39ffa8c96951556
Autor:
Brian Estrella, Manuel A Pazos, Edd C Ricker, Yun Kyoung Ryu, Ted B. Piorczynski, Yuxuan Liu, Seda Tolu, Jennifer E. Amengual
Publikováno v:
Blood. 140:358-359
Publikováno v:
Journal of Clinical Oncology. 41:16-16
16 Background: Randomized clinical trials have demonstrated the survival benefit provided by the addition of biologic drugs to chemotherapy (biochemotherapy) in patients with metastatic colorectal cancer (mCRC). However, Hispanic patients are underre
Survival analysis of patients with early and standard onset colorectal cancer: A single center study
Autor:
Dhruv Patel, Catarina Martins Maia, Michael Lyudmer, Seda Tolu, Adel Chergui, Riya Jayesh Patel, So Yeon Kim, Radhika Gali, Ana Acuna Villaorduna, Sanjay Goel
Publikováno v:
Journal of Clinical Oncology. 40:e15512-e15512
e15512 Background: While more aggressive clinical/pathological features have been consistently described in between patients with early-onset (EO) and standard-onset (SO) colorectal cancer (CRC), survival data have been conflicting. While some studie
Publikováno v:
Управленец, Vol 13, Iss 6, Pp 70-85 (2023)
Over the past two decades, the gaming industry has rapidly increased its popularity and gained a top spot in the entertainment sector. With this rise, customer relations and churn analysis have become even more prominent in gaming, as digital games a
Externí odkaz:
https://doaj.org/article/76a99582849847f88d64e70f1bcbf5e6
Autor:
Eunice S. Wang, Rena G. Lapidus, Seda Tolu, Laurie A. Ford, Elizabeth A. Griffiths, Brandon Carter-Cooper, Ashkan Emadi, Rawan Faramand, Meir Wetzler, Arash Etemadi
Publikováno v:
American Journal of Hematology. 90:E77-E79
Mutations in IDH1 and IDH2 occur in 15-20% of AML cases, resulting in the production of 2-hydroxyglutarate, which promotes aberrant hypermethylation of DNA in leukemic cells. Although these mutations have been shown to have prognostic implications fo
Autor:
Ashkan, Emadi, Rawan, Faramand, Brandon, Carter-Cooper, Seda, Tolu, Laurie A, Ford, Rena G, Lapidus, Meir, Wetzler, Eunice S, Wang, Arash, Etemadi, Elizabeth A, Griffiths
Publikováno v:
American journal of hematology. 90(5)
Mutations in IDH1 and IDH2 occur in 15-20% of AML cases, resulting in the production of 2-hydroxyglutarate, which promotes aberrant hypermethylation of DNA in leukemic cells. Although these mutations have been shown to have prognostic implications fo
Autor:
Arash Etemadi, Meir Wetzler, Eunice S. Wang, Brandon Carter-Cooper, Laurie A. Ford, Rena G. Lapidus, Ashkan Emadi, Seda Tolu, Elizabeth A. Griffiths
Publikováno v:
ResearcherID
Introduction: Mutations in IDH1 and IDH2 occur in 15-20% of AML cases, inducing the production of the oncometabolite, 2-hydroxyglutarate, which results in aberrant hypermethylation of DNA in leukemic cells. DNA methyltransferase inhibitors (DNMTI), w